SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Biotechnology

Healthcare
$29.68 +2.49%

+$0.45 today

Market cap
$993.14M
Beta
-0.34
P/E (TTM)
-14.1
EPS (TTM)
-$1.32
52W Low $17.06High $32.44

Volume 0.10M

Average 0.09M

SGP Total Current Liabilities

All obligations due within one year.

SpyGlass Pharma, Inc. Common StockNASDAQ: SGP

Total Current Liabilities · Q1 FY2026 · quarter ended Mar 2026

Total current liabilities of $6.67M in Q1 FY2026

Q1 FY2026 total current liabilities was $6.67M.

Context

  • Total current liabilities amounted to 2.6% of total assets at the end of Q1 FY2026.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$6.67M-22.3% QoQ
Last fiscal yearDec 2025
$8.58M— YoY
Total Current Liabilities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Total Current Liabilities history

USD · from the balance sheet

Latest · FY2025
8.58M USD
Year-over-year change
—

Total Current Liabilities vs competitors

How SGP compares with its peers on the latest reported figures

  • Peers report in different currencies, so total current liabilities is compared through growth and share of total assets rather than absolute size.
  • Total current liabilities amounts to 2.6% of total assets for SGP, versus a peer median of 13.0%.
SGP Competitors
Total Current Liabilities for SGP and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ALCAlcon Inc.Sep 2026$2.79B USD-6.5%+3.7%8.9%
BLCOBausch + Lomb CorporationJun 2026$1.89B USD+2.7%+14.0%13.6%
GKOSGlaukos CorporationJun 2026$102.33M USD+29.3%+11.9%11.1%
STAASTAAR Surgical CompanyApr 2026$60.99M USD-10.8%+9.8%13.5%
OCULOcular Therapeutix, Inc.Mar 2026$47.68M USD+25.7%+17.4%6.5%
OCSOculis Holding AGMar 2026CHF 43.73M CHF+10.8%+45.2%18.0%
EYPTEyePoint Pharmaceuticals, Inc.Mar 2026$37.46M USD-10.1%+2.3%13.0%
RXSTRxSight, Inc.Mar 2026$27.38M USD+20.4%+15.1%9.0%
SGHTSight Sciences, Inc.Mar 2026$18.16M USD+49.8%-14.8%16.6%
SGPSpyGlass Pharma, Inc. Common StockMar 2026$6.67M USD——2.6%
Peer median (excluding SGP) —+10.8%+11.9%13.0%

Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Intrinsic Alpha fair value

Locked

Current Price

$29.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.